Willingness to participate in clinical trials among African Americans and whites previously exposed to clinical research.

Academic Article


  • The objective of this study was to identify racial differences in willingness to participate in a population with previous exposure to clinical research. A survey instrument was administered to community-dwelling whites and African Americans who were voluntarily receiving a lay research and health education newsletter from a local Boston geriatric clinical research institution. The survey instrument assessed willingness to participate in 3 hypothetical clinical trials (diet trial for obesity, medication trial for hypertension [HTN], chemotherapy trial for cancer). Surveys were received from 473 whites and 279 African Americans (53% response rate) with mean age 74 (SD +/- 9). In multivariate models, race was not significantly related to willingness to participate in the multivariate models for any of the 3 trials. Previous trial participation was related to a higher odds of willingness to participate in the diet trial only (OR 1.8, 95% CI 1.2, 2.6). Lower levels of trust in one's primary care physician were associated with a lower odds of willingness to participate in clinical trials for the diet and HTN trials (OR 0.5, 95% CI 0.3, 0.8 and OR 0.6, 95% CI 0.3, 0.9, respectively). These findings suggest that, within populations previously exposed to clinical research, African Americans are no less willing to participate in clinical trials compared to whites.
  • Authors

    Published In


  • African Americans, Aged, Aged, 80 and over, Attitude to Health, Biomedical Research, Boston, Clinical Trials as Topic, European Continental Ancestry Group, Female, Humans, Male, Middle Aged, Patient Participation, Patient Selection, Surveys and Questionnaires, United States
  • Author List

  • Durant RW; Legedza AT; Marcantonio ER; Freeman MB; Landon BE
  • Start Page

  • 8
  • End Page

  • 19
  • Volume

  • 18
  • Issue

  • 1